Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer-Reference-Cited by-同舟云学术

Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer

Published:2015-02-20 Issue:3 Volume:32 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Meattini Icro,Francolini Giulio,Scotti Vieri,De Luca Cardillo Carla,Cappelli Sabrina,Meacci Fiammetta,Furfaro Ilaria Francesca,Muntoni Cristina,Scoccianti Silvia,Detti Beatrice,Mangoni Monica,Nori Jacopo,Orzalesi Lorenzo,Fambrini Massimiliano,Bianchi Simonetta,Livi Lorenzo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-015-0535-9.pdf

Reference20 articles.

1. Poole CJ, Earl HM, Hiller L, et al. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. N Engl J Med. 2006;355:1851–62.

2. Hesketh PJ, Kris MG, Grunberg SM, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol. 1997;15:103–9.

3. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC). Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia consensus conference. Ann Oncol. 1998;9:811–9.

4. Grunberg SM, Deuson RR, Mavros P, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer. 2004;100:2261–8.

5. The Italian Group for Antiemetic Research. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med. 2000;342:1554–9.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in China;Chinese Clinical Oncology;2020-10

2. Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy;Clinical Breast Cancer;2018-04

3. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study;Supportive Care in Cancer;2016-10-06

4. The more we use, the more we lose;Medical Oncology;2015-03-19

5. Efficacy and Safety of Aprepitant and Dexamethasone in the Prevention of Nausea and Vomiting from Neoadjuvant or Adjuvant Anthracyclines and Cyclophosphamide Combination Therapy in Patients with Breast Cancer;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2015